.png)
Pre-Cure utilizes advanced microfluidic technologies which provide versatility for customized tumor-on-a-chip. Instead of using a single measurement, our technology allows parallel measurement of multiple cell functions.
This transforms the tumor-on-a-chip concept to a patient-on-a-chip where the clinical journey is reflected in the best way.
Our technology results from extensive research conducted at the Nanomedicine & Tumor Microenvironment lab at the Hebrew University of Jerusalem led by Prof. Ofra Benny.
Come and explore the future of oncology with Pre-Cure's platform.
We can extract a wealth of biological-functional information from minimal size of fresh tissue samples.
Our platform offers predictions for both first and second line treatment strategies (chemotherapy and irradiation), affording the option of monotherapy or combination therapy.
Our bio-chip design is customizable, delivering personalized information for each patient and thereby improving treatment efficacy.
With our unique, patented biocompatible devices and designs, we can extract an abundance of biological-functional information from a minimal fresh tissue sample size.
This efficient process delivers crucial information to oncologists within a short timeframe (under 10 days), facilitating the selection of optimal therapeutic strategies.